Lyka Labs Limited (LYKALABS.BO)

INR 157.15

(2.23%)

Total Assets Summary of Lyka Labs Limited

Lyka Labs Limited's latest annual total assets in 2023 was 1.56 Billion INR , up 3.43% from previous year.
Lyka Labs Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
Lyka Labs Limited reported annual total assets of 1.51 Billion INR in 2022, down -18.37% from previous year.
Lyka Labs Limited reported annual total assets of 1.85 Billion INR in 2021, down -2.31% from previous year.
Lyka Labs Limited reported quarterly total assets of - INR for 2023 Q3, down -100.0% from previous quarter.
Lyka Labs Limited reported quarterly total assets of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Assets Chart of Lyka Labs Limited (2023 - 2009)

Historical Annual Total Assets of Lyka Labs Limited (2023 - 2009)

Year	Total Assets	Total Assets Growth
2023	1.56 Billion INR	3.43%
2022	1.51 Billion INR	-18.37%
2021	1.85 Billion INR	-2.31%
2020	1.9 Billion INR	-5.07%
2019	2 Billion INR	-7.28%
2018	2.15 Billion INR	-5.8%
2017	2.29 Billion INR	-8.97%
2016	2.51 Billion INR	4.8%
2015	2.4 Billion INR	-13.82%
2014	2.78 Billion INR	-15.34%
2013	3.29 Billion INR	13.97%
2012	2.88 Billion INR	2.26%
2011	2.82 Billion INR	-20.6%
2010	3.55 Billion INR	17.3%
2009	3.03 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q1	- INR	-100.0%
2023 Q4	1.56 Billion INR	0.0%
2023 Q2	1.51 Billion INR	0.0%
2023 FY	1.56 Billion INR	3.43%
2022 Q2	1.81 Billion INR	0.0%
2022 FY	1.51 Billion INR	-18.37%
2022 Q1	- INR	-100.0%
2022 Q4	1.51 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q4	1.85 Billion INR	0.0%
2021 FY	1.85 Billion INR	-2.31%
2021 Q2	1.97 Billion INR	0.0%
2020 Q4	1.9 Billion INR	0.0%
2020 FY	1.9 Billion INR	-5.07%
2020 Q1	- INR	-100.0%
2020 Q2	1.93 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2019 Q4	2 Billion INR	0.0%
2019 FY	2 Billion INR	-7.28%
2019 Q3	- INR	-100.0%
2019 Q2	2.15 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2018 Q4	2.15 Billion INR	0.0%
2018 FY	2.15 Billion INR	-5.8%
2018 Q1	- INR	0.0%
2017 FY	2.29 Billion INR	-8.97%
2016 FY	2.51 Billion INR	4.8%
2016 Q4	2.48 Billion INR	0.0%
2016 Q2	2.54 Billion INR	0.0%
2016 Q3	- INR	-100.0%
2016 Q1	- INR	-100.0%
2015 FY	2.4 Billion INR	-13.82%
2015 Q4	2.41 Billion INR	-4.98%
2015 Q3	2.54 Billion INR	0.0%
2015 Q2	2.54 Billion INR	0.0%
2015 Q1	- INR	-100.0%
2014 Q1	3.59 Billion INR	0.0%
2014 Q4	2.78 Billion INR	0.0%
2014 FY	2.78 Billion INR	-15.34%
2013 Q1	- INR	-100.0%
2013 Q3	- INR	-100.0%
2013 Q2	2.76 Billion INR	0.0%
2013 FY	3.29 Billion INR	13.97%
2012 Q4	2.88 Billion INR	0.0%
2012 FY	2.88 Billion INR	2.26%
2011 FY	2.82 Billion INR	-20.6%
2010 FY	3.55 Billion INR	17.3%
2009 FY	3.03 Billion INR	0.0%

Peer Total Assets Comparison of Lyka Labs Limited

Name	Total Assets	Total Assets Difference
Alfavision Overseas (India) Limited	1.78 Billion INR	12.229%
Biocon Limited	560.7 Billion INR	99.72%
Blue Jet Healthcare Limited	10.58 Billion INR	85.199%
Concord Biotech Limited	17 Billion INR	90.785%
Dishman Carbogen Amcis Limited	95.81 Billion INR	98.364%
FERMENTA BIOTECH LIMITED	5.47 Billion INR	71.392%
GENOMIC VALLEY BIOTECH LIMITED	43.33 Million INR	-3516.432%
Panacea Biotec Limited	12.4 Billion INR	87.368%
SAMSRITA LABS LIMITED	155.51 Million INR	-907.789%
Servoteach Industries Limited	1591.00 INR	-98506688.184%
SMS Lifesciences India Limited	3.9 Billion INR	59.868%
Supriya Lifescience Limited	9.21 Billion INR	82.988%
Syngene International Limited	61.51 Billion INR	97.452%
TAKE Solutions Limited	881.05 Million INR	-77.884%
Titan Biotech Limited	1.56 Billion INR	-0.092%
Transgene Biotek Limited	324.4 Million INR	-383.116%
Vanta Bioscience Limited	853.96 Million INR	-83.525%